Epicutaneous Application of CpG Oligodeoxynucleotides with Peptide or Protein Antigen Promotes the Generation of CTL
- 1 April 2004
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 122 (4) , 1042-1049
- https://doi.org/10.1111/j.0022-202x.2004.22411.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartmentBlood, 2002
- Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic CellsThe Journal of Experimental Medicine, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Bacterial DNA and CpG–Containing Oligodeoxynucleotides Activate Cutaneous Dendritic Cells and Induce IL–12 Production: Implications for the Augmentation of Th1 ResponsesInternational Archives of Allergy and Immunology, 1999
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Exact prediction of a natural T cell epitopeEuropean Journal of Immunology, 1991
- Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.The Journal of Experimental Medicine, 1990
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988